Injective vs JPool Staked SOL Staking
Side-by-side comparison of INJ and JSOL staking yields, risk, and key metrics. Updated every 4 hours.
Detailed comparison
Injective vs JPool Staked SOL: which should you stake?
Injective currently offers the higher APY at 6.52% compared to JPool Staked SOL's 5.39%. That's a 1.13 percentage point difference in annual yield.
In terms of market cap, Injective is the larger asset at $465.44M, which generally indicates more liquidity and lower volatility risk.
Both assets can be staked through various platforms and protocols. Consider diversifying across both rather than choosing one exclusively — this spreads your risk across different networks and ecosystems.
Injective vs JPool Staked SOL — common questions
Is Injective or JPool Staked SOL better for staking?
Injective currently offers a higher staking APY at 6.52% compared to JPool Staked SOL's 5.39%. However, the best choice depends on your risk tolerance, investment horizon, and portfolio strategy.
What is the APY difference between Injective and JPool Staked SOL?
Injective offers 6.52% APY while JPool Staked SOL offers 5.39% APY — a difference of 1.13 percentage points.
Which is safer to stake: INJ or JSOL?
Injective has a medium risk rating while JPool Staked SOL has a medium risk rating. Lower risk typically means a more established network with stronger validator infrastructure.
Can I stake both INJ and JSOL?
Yes, diversifying across multiple staking assets is a common strategy. Staking both Injective and JPool Staked SOL spreads your risk across different networks and protocols.